Atomoxetine Hydrochloride
"Atomoxetine Hydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A propylamine derivative and selective ADRENERGIC UPTAKE INHIBITOR that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.
| Descriptor ID |
D000069445
|
| MeSH Number(s) |
D02.092.831.085
|
| Concept/Terms |
Atomoxetine Hydrochloride- Atomoxetine Hydrochloride
- Hydrochloride, Atomoxetine
- N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride
- Atomoxetine HCl
- HCl, Atomoxetine
|
Below are MeSH descriptors whose meaning is more general than "Atomoxetine Hydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Atomoxetine Hydrochloride".
This graph shows the total number of publications written about "Atomoxetine Hydrochloride" by people in this website by year, and whether "Atomoxetine Hydrochloride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Atomoxetine Hydrochloride" by people in Profiles.
-
Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study. Depress Anxiety. 2022 04; 39(4):286-295.
-
Robustness of reliable change indices to variability in Parkinson's disease with mild cognitive impairment. Appl Neuropsychol Adult. 2016 Nov-Dec; 23(6):399-402.
-
Atomoxetine prevents dexamethasone-induced skeletal muscle atrophy in mice. J Pharmacol Exp Ther. 2014 Dec; 351(3):663-73.
-
A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
-
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008 Jul 01; 96(1-2):145-54.
-
Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications. Exp Clin Psychopharmacol. 2007 Oct; 15(5):501-9.
-
A pilot study of the effects of atomoxetine on driving performance in adults with ADHD. J Atten Disord. 2007 Feb; 10(3):306-16.
-
Postmortem tissue distribution of atomoxetine following fatal and nonfatal doses--three case reports. J Forensic Sci. 2006 Jan; 51(1):179-82.
-
Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder. Pharmacotherapy. 2004 Aug; 24(8):1020-36.